About Andira
Andira is a company based in Vancouver (Canada) founded in 2020 by Dana Lambert. Andira has raised $1.59 million across 5 funding rounds. Andira offers products and services including Silvanex™ Flex, Silvanex™ IV Site, Silvanex™ Topical, AND-259, and AND-254. Andira operates in a competitive market with competitors including Simulations Plus, Zevra, Sayre Therapeutics, Supreme Optimization and Life Science Connect, among others.
- Headquarter Vancouver, Canada
- Founders Dana Lambert
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.59 M (USD)
in 5 rounds
-
Latest Funding Round
$152.39 K (USD), Seed
Feb 26, 2026
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Andira
Andira offers a comprehensive portfolio of products and services, including Silvanex™ Flex, Silvanex™ IV Site, Silvanex™ Topical, AND-259, and AND-254.
Provides advanced wound care using cannabinoid technology
Prevents infections at IV insertion sites
Treats surgical site infections with cannabinoids
Targets breast cancer through cannabinoid-based innovation
Addresses mastectomy pain via therapeutic development
People of Andira
Unlock access to complete
Unlock access to complete
Funding Insights of Andira
Andira has successfully raised a total of $1.59M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $152.39 thousand completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Andira
Investment portfolio details for Andira
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Andira
Detailed financials for Andira
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Andira Comparisons
Peer comparison for Andira
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Andira
Andira operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Simulations Plus, Zevra, Sayre Therapeutics, Supreme Optimization and Life Science Connect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Simulation software is developed for chemoinformatics and drug discovery.
|
|
| Locked | Locked | Locked |
Marketing services are provided to biopharma companies.
|
|
| Locked | Locked | Locked |
Access to therapies for rare and life-threatening diseases is provided.
|
|
| Locked | Locked | Locked |
Digital marketing services are offered to the life sciences sector.
|
|
| Locked | Locked | Locked |
Marketing and commercialization services for biopharma sector are provided.
|
Detailed competitors of Andira
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Andira
Complete news archive for Andira
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Andira
Andira was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Andira is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Dana Lambert is the current CEO of Andira. They have also founded this company.
Andira is a funded company, having raised a total of $1.59M across 5 funding rounds to date.
Andira was founded in 2020 in Vancouver, Canada, as a digital pharmacotherapeutic platform targeted at healthcare providers. Operations center on the identification and development of natural compounds that hold potential for therapeutic applications. Services include tools for chemical discovery and pharmacotherapeutic support, with a focus on integrating natural substances into medical practices across the biotechnology sector.
Andira's top competitors include Simulations Plus, Zevra and Sayre Therapeutics.
Andira offers Silvanex™ Flex, Silvanex™ IV Site, Silvanex™ Topical, AND-259, and AND-254.